Scott Tarriff

Scott Tarriff has an estimated net worth of $49.1 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, EAGLE PHARMACEUTICALS, INC., Synthetic Biologics, Inc., and CLINICAL DATA INC.

2016 was Scott Tarriff's most active year for acquiring shares with 6 total transactions. Scott Tarriff's most active month to acquire stocks was the month of November. 2015 was Scott Tarriff's most active year for disposing of shares, totalling 23 transactions. Scott Tarriff's most active month to dispose stocks was the month of January. 2018 saw Scott Tarriff paying a total of $961,148.32 for 790,108 shares, this is the most they've acquired in one year. In 2015 Scott Tarriff cashed out on 216,222 shares for a total of $12,538,599.60, their largest year based on trade value.